Suppr超能文献

一种新分离的噬菌体BUCT609感染的潜在应用。

Potential application of a newly isolated phage BUCT609 infecting .

作者信息

Han Ke, Dong Yuqi, An Xiaoping, Song Lihua, Li Mengzhe, Fan Huahao, Tong Yigang

机构信息

College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, China.

出版信息

Front Microbiol. 2022 Nov 21;13:1001237. doi: 10.3389/fmicb.2022.1001237. eCollection 2022.

Abstract

() is widely distributed in nature and frequently causes nosocomial infections. In this work, the biological characteristics and genome of a new phage BUCT609 isolated from hospital sewage with strain No. 3015 as host was analyzed and its therapeutic effect was explored. It was observed by TEM that phage BUCT609 belongs to the with a 10 nm tail structure and a capsid with a diameter of about 50 nm. It has a short latent period (about 10 min) and its burst size is 382 PFU /cell when multiplicity of infection (MOI) is 0.01. Furthermore, it has a high survival rate in the environment with a pH range from 3 to 10 and temperature range from 4°C to 55°C. The complete genome of phage BUCT609 is linear double-stranded DNA of 43,145 bp in length, and the GC content is 58%. The genome sequence of phage BUCT609 shares <45% homology with other phages. No virulence genes and antibiotic resistance genes were found in bacteriophage BUCT609. animal experiments showed that the survival rate of mice infected with was significantly improved after the intranasal injection of phage BUCT609. Therefore, our study supports that phage BUCT609 could be used as a promising antimicrobial candidate for treating infections.

摘要

(某菌)在自然界广泛分布,常引起医院感染。在本研究中,对从医院污水中分离出的以3015菌株为宿主的新型噬菌体BUCT609的生物学特性和基因组进行了分析,并探索了其治疗效果。通过透射电子显微镜观察到噬菌体BUCT609属于具有10纳米尾部结构和直径约50纳米衣壳的(某种噬菌体类型)。它具有较短的潜伏期(约10分钟),当感染复数(MOI)为0.01时,其裂解量为382噬菌斑形成单位/细胞。此外,它在pH值为3至10、温度范围为4℃至55℃的环境中具有较高的存活率。噬菌体BUCT609的完整基因组是长度为43145碱基对的线性双链DNA,GC含量为58%。噬菌体BUCT609的基因组序列与其他噬菌体的同源性低于45%。在噬菌体BUCT609中未发现毒力基因和抗生素抗性基因。动物实验表明,经鼻内注射噬菌体BUCT609后,感染(某菌)的小鼠存活率显著提高。因此,我们的研究支持噬菌体BUCT609可作为治疗(某菌)感染的有前景的抗菌候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8401/9720304/892b3643ba95/fmicb-13-1001237-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验